Search

everythinglearnresearchcommunity

for

Search:↓

SOX9 helps determine stem cell roles by interacting with DNA and proteins that control gene activity.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Diuretics can cause serious side effects and should be used carefully.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Certain human skin cells marked by CD44 and ALDH are rich in stem cells capable of long-term skin renewal.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.